Opening book details…
About this book
Discovery of Potent Inhibitors of Streptococcus mutans Biofilm with Antivirulence Activity by Bhavitavya Nijampatnam; Parmanand Ahirwar; Piyasuda Pukkanasut; Holly Womack; Luke Casals; Hua Zhang; Xia Cai; Suzanne M. Michalek; Hui Wu; Sadanandan E. Velu is a book available to read on EtoBox.
- Author
- Bhavitavya Nijampatnam; Parmanand Ahirwar; Piyasuda Pukkanasut; Holly Womack; Luke Casals; Hua Zhang; Xia Cai; Suzanne M. Michalek; Hui Wu; Sadanandan E. Velu
- Published
- 2021
- Language
- EN
More by Bhavitavya Nijampatnam; Parmanand Ahirwar; Piyasuda Pukkanasut; Holly Womack; Luke Casals; Hua Zhang; Xia Cai; Suzanne M. Michalek; Hui Wu; Sadanandan E. Velu
Similar books
- The Discovery of Conformationally Constrained Bicyclic Peptidomimetics as Potent Hepatitis C NS5A Inhibitors — Wieslaw M. Kazmierski, Nagaraju Miriyala, David K. Johnson & Sam Baskaran (2021)
- Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors — Upul K. Bandarage; Alex M. Aronov; Jingrong Cao; Jon H. Come; Kevin M. Cottrell; Robert J. Davies; Simon Giroux; Marc Jacobs; Sudipta Mahajan; David Messersmith; Cameron S. Moody; Rebecca Swett; Jinwang Xu (2021)
- Discovery of Aminopyrazole Derivatives as Potent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3 — Ryan A. Brawn; Andrew Cook; Kiyoyuki Omoto; Jiyuan Ke; Craig Karr; Federico Colombo; Milena Virrankoski; Sudeep Prajapati; Dominic Reynolds; David M. Bolduc; Tuong-Vi Nguyen; Patricia Gee; Deanna Borrelli; Benjamin Caleb; Shihua Yao; Sean Irwin; ... (2021)
- Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors — Yangbo Feng; HaJeung Park; Luke Bauer; Jae Cheon Ryu; Sung OK Yoon (2021)
- Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) Inhibitor — Brian J. Groendyke; Behnam Nabet; Mikaela L. Mohardt; Haisheng Zhang; Ke Peng; Eriko Koide; Calvin R. Coffey; Jianwei Che; David A. Scott; Adam J. Bass; Nathanael S. Gray (2021)
- Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease — Katsushi Katayama; Ken Ishii; Hideki Terashima; Eisuke Tsuda; Makoto Suzuki; Keiichi Yotsumoto; Kumiko Hiramoto; Isao Yasumatsu; Munefumi Torihata; Takashi Ishiyama; Tsuyoshi Muto; Takahiro Katagiri (2021)